Clinical Trial Update: Testosterone Replacement Therapy Decreases Plasma Paraoxonase 1 Enzyme Activity In Male Patients With Hypogonadism [Phase 4]

View source ↗

Summary

Phase 4 trial results show that testosterone replacement therapy decreases plasma paraoxonase 1 enzyme activity in male patients with hypogonadism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism

Drugs mentioned

• Testosterone replacement therapy (testosterone)

Snippet

Sponsor: Gulhane School of Medicine | Conditions: Hypogonadism | Phase 4 | Status: COMPLETED